Spyre Therapeutics, Inc. · NASDAQ:SYRE

Turtle Cameron sold 15,000 Spyre Therapeutics, Inc. shares (Form 4)

Traded Apr 1, 2026 · Filed Apr 3, 2026

On Apr 1, 2026, Turtle Cameron (Director, Chief Executive Officer) sold 15,000 Spyre Therapeutics, Inc. shares at an average US$49.33 for US$740K under a trading plan, leaving 627,540 shares. Filed Apr 3, 2026 (Form 4).

Sold
15,000 shares
Price
US$49.33 average (US$49.20 to US$49.92)
Value
US$740K
Holding after
627,540 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Common StockSale12,344US$49.20630,196Direct
Apr 1, 2026Common StockSale2,656US$49.92627,540Direct

Source

View original at SEC

Related